• Quinolone–Coumarin Hybrids Against Toxoplasma gondii

  2026-09-15

  A 2024 Acta Parasitologica study evaluated 12 quinolone–coumarin hybrids derived from fluoroquinolones and novobiocin against intracellular Toxoplasma gondii in vitro. Several candidates, together with novobiocin, reduced infection, proliferation, and plaque formation while maintaining better selectivity than pyrimethamine, providing a useful starting point for anti-Toxoplasma lead discovery.

• From Hypoxia to Actionable Cell Viability Data

  2026-09-15

  A mechanistic and strategic guide to using live/dead fluorescence readouts in high-density glioblastoma models, with practical guidance for translating hypoxia-driven biology into more informative cytotoxicity and viability decisions.

• Bestatin Hydrochloride: Mechanism & Research Use

  2026-09-14

  Bestatin hydrochloride, also called Ubenimex, is a research inhibitor of aminopeptidase N/CD13 and aminopeptidase B. Evidence supports its use in angiogenesis inhibition, tumor biology, and neuropeptide-processing studies, but assay-specific dosing and domain limits must be respected.

• Linoleic Acid (C18:2): Practical Assay Guide

  2026-09-14

  Linoleic Acid (SKU C3108) provides a defined omega-6 fatty acid reagent for studying membrane behavior, lipid oxidation, epithelial migration, erythrocyte injury, and essential fatty acid deficiency. This guide covers solvent selection, fresh-solution handling, assay controls, and interpretation limits; it should not be treated as a dose-validated disease model or as evidence for a single redox mechanism.

• ECL Validation of Syringin–Sunitinib Mechanisms

  2026-09-13

  A translational framework for using HRP-based ECL detection to validate the EGFR/PI3K/Akt mechanism proposed for syringin-enhanced sunitinib activity in renal cell carcinoma, while separating analytical signal from biological causality.

• CDK4/6–BET Synergy in Pancreatic Cancer

  2026-09-12

  Gu et al. show that CDK4/6 inhibition can restrain pancreatic tumor-cell proliferation while unexpectedly enhancing migration, invasion, and epithelial-to-mesenchymal transition. Their study identifies GSK3β-mediated Wnt/β-catenin activation as a mechanism of this liability and demonstrates that BET inhibition can restore antitumor activity in combination with palbociclib.

• EPZ-6438: An EZH2 Inhibitor for Resistance Biology

  2026-09-11

  EPZ-6438 is a selective EZH2 inhibitor for dissecting H3K27me3-dependent transcription and treatment resistance. This guide connects chromatin pharmacology with time-resolved melanoma assays, lymphoma models, and practical experimental design.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-11

  Shapira-Netanelov and colleagues developed gastric cancer assembloids by combining patient-matched tumor organoids with stromal cell subpopulations derived from the same tumor. The model reproduced tumor–stroma effects on gene expression and drug sensitivity, offering a more physiologically relevant framework for resistance studies and personalized treatment research.

• Phenacetin: Structure, Solubility, and Research Use

  2026-09-10

  Phenacetin, also called N-(4-ethoxyphenyl)acetamide, is a historically used non-opioid analgesic and antipyretic with no established anti-inflammatory action. Its defined identity, solvent-dependent solubility, analytical quality data, and safety limitations make it relevant to controlled scientific research use and pharmacokinetic studies.

• 5-(N,N-dimethyl)-Amiloride in Endothelial Research

  2026-09-10

  Use 5-(N,N-dimethyl)-Amiloride hydrochloride to connect Na+/H+ exchanger activity with intracellular pH regulation, endothelial barrier failure, and cardiac ion-transport phenotypes. This workflow pairs a reversible pharmacological perturbation with moesin, permeability, sodium, and signaling readouts for more informative sepsis and ischemia-reperfusion injury studies.

• NLRP3 Astrocyte Phenotypes in Morphine Tolerance

  2026-09-09

  Yuan et al. link spinal NLRP3 inflammasome activation with a shift toward the neurotoxic A1 astrocyte phenotype during morphine tolerance. Pharmacological inhibition with MCC950 slowed tolerance development and normalized inflammatory and astrocyte-associated markers, providing a mechanistic framework for studying glia-driven opioid adaptation.

• MRSA Vesicles, IL-8, and Oral Cancer Progression

  2026-09-09

  A 2026 study identifies extracellular vesicles from methicillin-resistant Staphylococcus aureus as active drivers of oral squamous cell carcinoma growth, rather than passive products of infection. Its experiments connect vesicle uptake with ERK/c-Jun activation, IL-8 production, CXCR1 signaling, CCL2 output, and JAK/STAT5A-dependent proliferation, providing a mechanistic framework for studying infection-associated tumor progression.

• Carbapenemase Gene Transmission in Guangdong CREC

  2026-09-08

  Chen et al. characterize carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae collected from eight teaching hospitals in Guangdong during 2022–2024. By combining gene localization, susceptibility testing, conjugation, mobile-element analysis, and ERIC-PCR, the study links plasmid carriage with multidrug resistance and substantial horizontal-transfer potential.

• Methoxy-X04 for Amyloid Plaque Imaging Workflows

  2026-09-08

  Methoxy-X04 combines blood-brain barrier permeability with high-affinity amyloid labeling, supporting both in vivo plaque mapping and controlled tissue assays. This workflow-focused guide shows how to use the fluorescent amyloid beta probe to evaluate plaque clearance, microglial interventions, and cerebrovascular amyloid while avoiding common interpretation and handling errors.

• Decitabine Priming Expands CD8+ Progenitor Tex

  2026-09-07

  Li et al. show that low-dose decitabine can improve anti–PD-1 efficacy by expanding and functionally sustaining CD8+ progenitor exhausted T cells rather than simply intensifying checkpoint blockade. Their tumor-model and molecular data identify JunD-dependent AP-1 activity as a mechanistic link between epigenetic priming, progenitor-cell proliferation, and tumor control.

8431 records 1/563 page Next 12345 下5页 Last page